Search results
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why
Zacks via Yahoo Finance· 1 year agoValneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance...
Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe
Zacks via Yahoo Finance· 2 years agoValneva (VALN) slides on a proposed remediation plan update after receiving the European...
Valneva Nearly Doubles After Pfizer Invests $95 Million For A Hefty Stake
Investor's Business Daily· 2 years agoValneva stock rocketed Tuesday on a $95 million investment from Pfizer, its Lyme disease vaccine...
Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoValneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good day and...
Valneva Shares Topple As It Hits Ethics Roadblock With Pfizer In Lyme Disease Test
Investor's Business Daily· 1 year agoValneva stock plummeted Friday after Pfizer said it will drop roughly half of the participants...
All You Need to Know About Valneva SE Sponsored ADR (VALN) Rating Upgrade to Buy
Zacks via Yahoo Finance· 2 years agoValneva SE Sponsored ADR (VALN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
EU watchdog backs Valneva's COVID shot as contract talks go on
Reuters via Yahoo News· 2 years ago(Reuters) -Valneva's COVID-19 vaccine was endorsed by the European Medicines Agency (EMA) on...
Climate change puts Lyme disease in focus for France's Valneva after COVID blow
Reuters via Yahoo News· 2 years agoWith climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big...
Valneva Cuts FY22 COVID-19 Vaccine Sales Outlook, Needs Funding To Invest In Next-Gen COVID-19 Shot
Benzinga via Yahoo Finance· 2 years agoValneva SE (NASDAQ: VALN) cut its FY22 revenue outlook citing lower demand for its anti-COVID shot...
Valneva sells regulatory ‘fast pass’ for $103M
BioPharma Dive via Yahoo Finance· 4 months agoVaccine maker Valneva on Monday said it has sold a priority review voucher to an undisclosed buyer for $103 million. The voucher, a sort of regulatory...